Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan · Delayed Price · Currency is TWD 11.75
+0.05 (0.43%)
Sep 18, 2026, 1:30 PM CST
Cowealth Medical Holding Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,899 | 2,956 | 4,193 | 4,813 | 5,626 | 5,140 | |
Revenue Growth | -21.10% | -29.49% | -12.88% | -14.46% | 9.47% | 8.85% |
Cost of Revenue | 2,493 | 2,564 | 3,401 | 3,828 | 4,522 | 4,082 |
Gross Profit | 406.64 | 392.18 | 791.52 | 984.45 | 1,104 | 1,058 |
Selling, General & Admin | 546.68 | 555.18 | 683.78 | 726.97 | 701.99 | 687.62 |
Research & Development | 20.51 | 16.58 | 16.7 | 13.96 | 12.36 | - |
Operating Expenses | 702.3 | 667.6 | 694.39 | 720.28 | 734.62 | 718.09 |
Operating Income | -295.66 | -275.42 | 97.13 | 264.17 | 369.83 | 339.84 |
Interest Expense | -22.2 | -22.72 | -28.92 | -34.74 | -24.97 | -24.39 |
Interest & Investment Income | 16.84 | 20.95 | 11.28 | 20.41 | 37.25 | 10.58 |
Earnings From Equity Investments | -0.96 | -1.33 | 0.64 | 0.5 | 0.11 | -0.07 |
Currency Exchange Gain (Loss) | 2.43 | -8.32 | 0.74 | -1.49 | -1.37 | -1.59 |
Other Non Operating Income (Expenses) | 0.05 | 0.16 | 4.36 | -6.05 | 5.92 | 10.38 |
EBT Excluding Unusual Items | -299.51 | -286.69 | 85.22 | 242.79 | 386.76 | 334.75 |
Gain (Loss) on Sale of Investments | 1.65 | 1.19 | 1.82 | 14.87 | -0.14 | - |
Gain (Loss) on Sale of Assets | -0.02 | -0.01 | 1.74 | 0.63 | -0.79 | -0.02 |
Other Unusual Items | -0 | 0.21 | 0.14 | 0.01 | 2.52 | - |
Pretax Income | -297.88 | -285.3 | 88.92 | 258.31 | 388.34 | 334.74 |
Income Tax Expense | 50.58 | 45.81 | 40.93 | 119.95 | 153.14 | 118.82 |
Earnings From Continuing Operations | -348.46 | -331.11 | 48 | 138.36 | 235.2 | 215.91 |
Minority Interest in Earnings | 100.13 | 84.55 | -47.37 | -89.25 | -141.08 | -76.45 |
Net Income | -248.33 | -246.56 | 0.63 | 49.11 | 94.12 | 139.46 |
Net Income to Common | -248.33 | -246.56 | 0.63 | 49.11 | 94.12 | 139.46 |
Net Income Growth | - | - | -98.72% | -47.82% | -32.52% | 12.12% |
Shares Outstanding (Basic) | 76 | 77 | 77 | 77 | 77 | 77 |
Shares Outstanding (Diluted) | 76 | 77 | 77 | 77 | 77 | 78 |
Shares Change | -2.16% | - | -0.03% | -0.02% | -0.02% | 0.02% |
EPS (Basic) | -3.28 | -3.18 | 0.01 | 0.63 | 1.22 | 1.80 |
EPS (Diluted) | -3.28 | -3.18 | 0.01 | 0.63 | 1.21 | 1.80 |
EPS Growth | - | - | -98.71% | -47.93% | -32.78% | 12.07% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -567.13 | 6.46 | 411.98 | -161.34 | -286.27 | -152.91 |
Free Cash Flow Per Share | -7.48 | 0.08 | 5.32 | -2.08 | -3.69 | -1.97 |
Dividend Per Share | - | - | - | 0.400 | 1.600 | 1.500 |
Dividend Growth | - | - | - | -75.00% | 6.67% | 25.00% |
Gross Margin | 14.03% | 13.27% | 18.88% | 20.46% | 19.63% | 20.58% |
Operating Margin | -10.20% | -9.32% | 2.32% | 5.49% | 6.57% | 6.61% |
Profit Margin | -8.57% | -8.34% | 0.01% | 1.02% | 1.67% | 2.71% |
Free Cash Flow Margin | -19.56% | 0.22% | 9.83% | -3.35% | -5.09% | -2.97% |
EBITDA | -263.9 | -241.38 | 130.13 | 315.66 | 405.52 | 388.75 |
EBITDA Margin | -9.10% | -8.16% | 3.10% | 6.56% | 7.21% | 7.56% |
D&A For EBITDA | 31.77 | 34.04 | 33 | 51.48 | 35.7 | 48.91 |
EBIT | -295.66 | -275.42 | 97.13 | 264.17 | 369.83 | 339.84 |
EBIT Margin | -10.20% | -9.32% | 2.32% | 5.49% | 6.57% | 6.61% |
Effective Tax Rate | - | - | 46.02% | 46.44% | 39.43% | 35.50% |